Phibro Animal Health Corporation (PAHC) Can’t Burn Your Long Portfolio. Just Reaches 52-Week High

April 23, 2018 - By Dolores Ford

Investors sentiment decreased to 1.41 in 2017 Q4. Its down 0.07, from 1.48 in 2017Q3. It worsened, as 17 investors sold Phibro Animal Health Corporation shares while 42 reduced holdings. 25 funds opened positions while 58 raised stakes. 19.14 million shares or 1.25% less from 19.38 million shares in 2017Q3 were reported.
Texas Permanent School Fund has invested 0.01% in Phibro Animal Health Corporation (NASDAQ:PAHC). Moreover, Vanguard Group Incorporated Inc has 0% invested in Phibro Animal Health Corporation (NASDAQ:PAHC). Metropolitan Life Insurance Com Ny has 6,518 shares for 0% of their portfolio. Moreover, Caprock Group Inc Inc Inc has 0.05% invested in Phibro Animal Health Corporation (NASDAQ:PAHC) for 7,595 shares. Goldman Sachs Grp owns 476,391 shares or 0% of their US portfolio. Strs Ohio holds 0% of its portfolio in Phibro Animal Health Corporation (NASDAQ:PAHC) for 20,400 shares. Pnc Svcs Group Inc holds 0% or 471 shares in its portfolio. State Of Wisconsin Investment Board has invested 0% in Phibro Animal Health Corporation (NASDAQ:PAHC). 7,772 are held by Old Natl Financial Bank In. Dimensional Fund Advisors Limited Partnership invested in 0.01% or 478,044 shares. Envestnet Asset Mgmt has invested 0% of its portfolio in Phibro Animal Health Corporation (NASDAQ:PAHC). Zurcher Kantonalbank (Zurich Cantonalbank) holds 646 shares. Principal Grp Inc reported 156,387 shares stake. Ameriprise Fincl reported 401,890 shares. 24,074 were reported by First Quadrant Limited Partnership Ca.

Since February 9, 2018, it had 0 buys, and 13 selling transactions for $12.62 million activity. BENDHEIM JACK had sold 36,000 shares worth $1.40M. On Wednesday, February 14 the insider Miller Larry Lee sold $630,886. 10,000 shares were sold by Warras Dean J, worth $356,200 on Friday, February 9. 23,163 shares were sold by Bendheim Daniel M, worth $926,717.

The stock of Phibro Animal Health Corporation (NASDAQ:PAHC) hit a new 52-week high and has $46.59 target or 6.00 % above today’s $43.95 share price. The 9 months bullish chart indicates low risk for the $1.77B company. The 1-year high was reported on Apr, 23 by Barchart.com. If the $46.59 price target is reached, the company will be worth $105.96M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.11% or $0.05 during the last trading session, reaching $43.95. About 18,747 shares traded. Phibro Animal Health Corporation (NASDAQ:PAHC) has risen 41.44% since April 23, 2017 and is uptrending. It has outperformed by 29.89% the S&P500.

Analysts await Phibro Animal Health Corporation (NASDAQ:PAHC) to report earnings on May, 7 after the close. They expect $0.44 EPS, up 18.92 % or $0.07 from last year’s $0.37 per share. PAHC’s profit will be $17.68M for 24.97 P/E if the $0.44 EPS becomes a reality. After $0.44 actual EPS reported by Phibro Animal Health Corporation for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

Phibro Animal Health Corporation (NASDAQ:PAHC) Ratings Coverage

Among 3 analysts covering Phibro Animal Health (NASDAQ:PAHC), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Phibro Animal Health has $45.0 highest and $36 lowest target. $40’s average target is -8.99% below currents $43.95 stock price. Phibro Animal Health had 3 analyst reports since February 6, 2018 according to SRatingsIntel. Piper Jaffray maintained the shares of PAHC in report on Wednesday, February 7 with “Buy” rating. Credit Suisse maintained it with “Neutral” rating and $39 target in Tuesday, February 6 report. Morgan Stanley maintained it with “Underweight” rating and $36 target in Wednesday, February 7 report.

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition firm primarily in the United States. The company has market cap of $1.77 billion. It operates through three divisions: Animal Health, Mineral Nutrition, and Performance Products. It has a 28.58 P/E ratio. The firm develops, makes, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Phibro Animal Health Corporation (NASDAQ:PAHC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: